Title List مقالات لاتين Coronary Endarterectomy: The Choice of Tactics is Dictated by the Lay of the Land Correcting bias due to misclassification in the estimation of logistic regression models

بر اساس عنوان

1

Coronary Endarterectomy: The Choice of Tactics is Dictated by the Lay of the Land

2

Coronary endothelial dysfunction after Kawasaki disease

3

Coronary Endothelial Dysfunction After Kawasaki Disease: Evaluation by Intracoronary Injection of Acetylcholine

4

Coronary endothelial dysfunction and hyperlipidemia are independently associated with diastolic dysfunction in humans

5

Coronary endothelial dysfunction and inflammation of coronary atherosclerosis

6

Coronary endothelial dysfunction and myocardial cell damage in chronic stable idiopathic dilated cardiomyopathy

7

Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy

8

Coronary endothelial dysfunction in the early months after heart transplantation

9

Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress

10

Coronary endothelial dysfunction is not rapidly reversible with ascorbic acid

11

Coronary Endothelial Dysfunction Precedes Heart Failure and Reduction of Coronary Reserve in Awake Dogs

12

Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease

13

Coronary endothelial injury after local occlusion on the human beating heart

14

Coronary Endothelial Vasomotor Function and Vascular Remodeling in Heart Transplant Recipients Randomized for Tacrolimus or Cyclosporine Immunosuppression Original Research Article

15

Coronary endothelium expresses a pathologic gene pattern compared to aortic endothelium: Correlation of asynchronous hemodynamics and pathology in vivo

16

Coronary end-to-side sleeve anastomosis using adhesive in off-pump bypass grafting in the pig

17

Coronary events and coronary care: MONICA project

18

Coronary events and coronary care: MONICA project

19

Coronary events and coronary care: MONICA project

20

Coronary events and coronary care: MONICA project

21

Coronary fistula between the left anterior descending coronary artery and the pulmonary artery: Two case reports

22

Coronary Flow Assessment in Unstable Angina/non ST-segment Elevation Myocardial Infarction Patients via Thrombolysis in Myocardial Infarction Frame Count in Angiography

23

Coronary Flow Dynamics Measured by Computed Tomography Angiography

24

Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries

25

Coronary flow reserve and brachial artery reactivity in patients with chest pain and “false positive” exercise-induced ST-segment depression

26

Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension

27

Coronary Flow Reserve Assessed by Transesophageal Echocardiography Identifies Early Restenosis of the Left Anterior Descending Coronary Artery Angioplasty

28

Coronary flow reserve assessment by dobutamine transesophageal doppler echocardiography

29

Coronary flow reserve assessment by dobutamine transesophageal doppler echocardiography

30

Coronary flow reserve assessment from average peak velocity profiles alone must be judged with caution

31

Coronary Flow Reserve Before and After Coronary Artery Bypass Surgery

32

Coronary flow reserve does not adequately interrogate coronary microvascualr function

33

Coronary Flow Reserve During Coronary Angioplasty in Patients With Recent Myocardial Infarction: Relation to Stenosis and Myocardial Viability

34

Coronary flow reserve impairment predicts cardiac events in heart transplant patients with preserved left ventricular function

35

Coronary flow reserve improves after aortic valve replacement for aortic stenosis: an adenosine transthoracic echocardiography study

36

Coronary flow reserve in composite arterial Y grafts

37

Coronary Flow Reserve in Hypertensive Patients With Hypercholesterolemia and Without Coronary Heart Disease

38

Coronary Flow Reserve in the Left Anterior Descending Artery Patients, Diagnostic and Prognostic Value of Doppler Echocardiogrphy

39

Coronary flow reserve is also impaired in patients with subclinical hypothyroidism

40

Coronary flow reserve is impaired in patients with aortic valve calcification

41

Coronary flow reserve is impaired in patients with slow coronary flow

42

Coronary Flow Reserve Is Impaired in Young Men With Familial Hypercholesterolemi

43

Coronary flow reserve may predict myocardial recovery after myocardial infarction in patients with TIMI grade 3 flow, ,

44

Coronary flow reserve measurement in the coronary sinus in pre and post CABG status

45

Coronary flow reserve of the angiographically normal left anterior descending coronary artery in patients with remote coronary artery disease

46

Coronary flow reserve or brachial artery flow to assess endothelial dysfunction: is it time to look at the heart again?

47

Coronary Flow Reserve With a Turbo: A Warning for the Use of Adenosine as a Provocative Test in Patients Receiving Ticagrelor?

48

Coronary flow studies for risk stratification in multivessel disease: A physiologic bridge too far?

49

Coronary flow velocity changes after intravenous dipyridamole infusion: Measurements using intravascular Doppler guide wire documentation of flow inhomogeneity

50

Coronary flow velocity immediately after primary coronary stenting as a predictor of ventricular wall motion recovery in acute myocardial infarction

51

Coronary flow velocity reserve and indices describing aortic distensibility in patients after coronary angiography

52

Coronary flow velocity reserve does not correlate with TIMI frame count in patients undergoing non-emergency percutaneous coronary intervention Original Research Article

53

Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease : Results from the pilot phase of the Women’s Ischemi Syndrome Evaluation (WISE) Study

54

Coronary flow, VO2 peak and anaerobic threshold in patients with dilated cardiomyopathy

55

Coronary flow: how far can we go with echocardiography?

56

Coronary Flow: The Holy Grail of Echocardiography?

57

Coronary grafting using a temporary intraluminal shunt instead of heart-lung bypass

58

Coronary Health Improvement Project (CHIP) is associated with improved nutrient intake and decreased depression

59

Coronary heart disease and associated risk factors in Qazvin: a population-based study

60

Coronary heart disease and chlamydia pneumoniae DNA in blood mononuclear cells

61

Coronary heart disease and lipid-modifying treatment in african american patients

62

Coronary heart disease and vitamin E

63

Coronary heart disease deaths and infarctions in people with little or no coronary calcium

64

Coronary heart disease in Chile

65

Coronary heart disease in Indian Asians

66

Coronary heart disease in Indian Asians

67

Coronary Heart Disease in Patients With Diabetes: Part I: Recent Advances in Prevention and Noninvasive Management Review Article

68

Coronary Heart Disease in Patients With Diabetes: Part II: Recent Advances in Coronary Revascularization Review Article

69

Coronary heart disease in people of south-Asian origin

70

Coronary heart disease in seven countries

71

Coronary heart disease in South Asia: Need to redefine risk

72

Coronary heart disease inequalities: deaths and the socio-economic environment in Nottingham, England

73

Coronary heart disease is a multifactorial disease

74

Coronary heart disease mortality among Arab and Jewish residents of Jerusalem

75

Coronary Heart Disease Mortality Among Young Adults in the U.S. From 1980 Through 2002: Concealed Leveling of Mortality Rates Original Research Article

76

Coronary heart disease mortality and sudden death among the 35–44-year age group in Allegheny County, Pennsylvania

77

Coronary heart disease mortality for six ethnic groups in California, 1990–2000

78

Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study

79

Coronary heart disease risk factors and menopause: a study in 1684 French women Original Research Article

80

Coronary heart disease risk factors in urban bus drivers

81

Coronary heart disease risk-factor profile in a lower middles class urban community in Pakistan

82

Coronary heart disease still dropping in UK

83

CORONARY HEART DISEASE TOGETHER WITH DIABETES POSES A SERIOUS HEALTH THREAT

84

Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: Meta-analyses of prospective studies, , ,

85

Coronary heart disease, shared care, and cholesterol

86

Coronary heart disease, stroke, and hypertension in a U.S. National cohort: The NHANES I Epidemiologic Follow-up Study

87

Coronary heart disease, type 2 diabetes mellitus and cardiovascular disease risk factors: a study on a middle-aged and elderly population

88

Coronary heart disease: Intervention for intimate relationship issues Original Research Article

89

Coronary Heart Disease: Pandemic in a True Sense

90

Coronary heart disease: where have we been and where are we going?

91

Coronary heart disease:: At the interface of molecular genetics and preventive medicine

92

Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon

93

Coronary hemodynamics in patients with symptomatic hypertrophic cardiomyopathy

94

Coronary hemodynamics of stent implantation after suboptimal and optimal balloon angioplasty

95

Coronary hybrid revascularization from January 1997 to January 2001: a clinical follow-up

96

Coronary in-stent restenosis following beta brachytherapy A histopathological examination

97

Coronary in-stent restenosis: Current status and future strategies

98

Coronary Insufficiency After Stentless Aortic Root Replacement: Risk Factors and Solutions

99

Coronary insufficiency in children: Review of literature and report of a rare case with unknown aetiology

100

Coronary intervention at hospitals without on-site cardiac surgery: are we pushing the envelope too far?

101

Coronary Intervention Without a Safety Net

102

Coronary Intervention, Restenosis and Complications

103

Coronary interventional procedures in pediatric heart transplant recipients with cardiac allograft vasculopathy

104

Coronary interventions: clinical outcomes and non-stent techniques

105

Coronary interventions: keeping score

106

Coronary intravascular ultrasound: implications for understanding the development and potential regression of atherosclerosis

107

Coronary involvement in Takayasuʹs arteritis

108

Coronary ischemia and percutaneous intervention

109

Coronary ischemia induced Wolf Parkinson White syndrome

110

Coronary ischemic disease, arterial stiffness, and pulse pressure

111

Coronary Ischemic Events after First Atrial Fibrillation: Risk and Survival

112

Coronary lesions at increased risk

113

Coronary lumen at six-month follow-up of a new radiopaque cordis tantalum stent using quantitative angiography and intracoronary ultrasound

114

Coronary Magnetic Resonance Imaging: Coming of Age

115

Coronary malperfusion due to type a aortic dissection: mechanism and surgical management

116

Coronary microcirculation evaluation with transesophageal echocardiography Doppler in type II diabetics

117

Coronary microcirculation: Physiology and mechanics

118

Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina

119

Coronary microembolization

120

Coronary microembolization

121

Coronary Microembolization: the Role of TNF- α in Contractile Dysfunction

122

Coronary microvascular abnormalities in Chagasʹ disease

123

Coronary microvascular dilation is impaired during cold pressor test in diabetic patients with angiographically normal coronary arteries

124

Coronary Microvascular Dysfunction and Diastolic Load Correlate With Cardiac Troponin T Release Measured by a Highly Sensitive Assay in Patients With Nonischemic Heart Failure

125

Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE study

126

Coronary microvascular endothelial cell growth regulates expression of the gene encoding p22-phox

127

Coronary Microvascular Function and Cortical Pain Processing in Patients With Silent Positive Exercise Testing and Normal Coronary Arteries

128

Coronary microvascular function and myocardial metabolism in patients with dilated cardiomyopathy

129

Coronary microvascular function and myocardial metabolism in the pig model of pacing induced progressive LV dysfunction

130

Coronary Microvascular Reactivity After Ischemic Cold Storage and Reperfusion

131

Coronary Microvascular Reactivity to Adenosine Predicts Adverse Outcome in Women Evaluated for Suspected Ischemia: Results From the National Heart, Lung and Blood Institute WISE (Womenʹs Ischemia Syndrome Evaluation) Study

132

Coronary microvascular response to intracoronary administration of nicorandil

133

Coronary microvascular spasm and angina pectoris

134

Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina

135

Coronary microvascular spasm in patients with vasospastic angina

136

Coronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitor

137

Coronary morphologic findings after stent implantation

138

Coronary MRI: More Pretty Pictures or Present-Day Value?

139

Coronary Multidetector Computed Tomography: A New Standard for Preoperative Risk Assessment?

140

Coronary Myocardial Bridges: Pathophysiology and Clinical Relevance

141

Coronary narrowing secondary to compression by pericardial hydatid cyst

142

Coronary no-flow and ventricular tachycardia associated with habitual marijuana use

143

Coronary No-reflow Phenomenon: A Review of Therapeutic Pharmacological Agents

144

Coronary obstruction by a calcific pericardial ring

145

Coronary operations in octogenarians: can we select the patients?

146

Coronary operations in patients with spinal cord injury

147

Coronary ostial enlargement to prevent stenosis after prosthetic aortic valve replacement

148

Coronary ostial patch angioplasty in children

149

Coronary ostial reconstruction

150

Coronary Ostial Stenosis After Aortic Valve Replacement, Revisited

151

Coronary perforation during unprotected left main angioplasty. Management with conservative approach: a case report

152

Coronary perforation managed with covered stent

153

Coronary perfusate composition influences diastolic properties, myocardial water content, and histologic characteristics of the rat left ventricle

154

Coronary perfusion methods during off-pump coronary artery bypass: results of a randomized clinical trial

155

Coronary perfusion pressure during cardiopulmonary resuscitation

156

Coronary plague instability in severe acute respiratory syndrome

157

Coronary plaque as a replacement for age as a risk factor in global risk assessment

158

Coronary Plaque Burden and Cardiovascular Risk Factors: Single-Point Versus Serial Assessment

159

Coronary plaque burden detected by multislice computed tomography after acute myocardial infarction with near-normal coronary arteries by angiography

160

Coronary plaque composition of nonculprit lesions, assessed by in vivo intracoronary ultrasound radio frequency data analysis, is related to clinical presentation

161

Coronary plaque composition, macrophage infiltration and tissue factor content in patients with diabetes mellitus

162

Coronary Plaque Composition: Multifactorial Contribution

163

Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease

164

Coronary plaque morphologic characteristics early and late after heart transplantation: In vivo analysis with intravascular ultrasonography,

165

Coronary plaque regression: role of low density lipoprotein-apheresis

166

Coronary Plaque Rupture and Vessel Remodeling

167

Coronary pseudoaneurysm: An uncommon cause of P.U.O. after a common procedure: An interesting case report

168

Coronary Pseudoaneurysm: An Unreported Complication of Castleman’s Disease

169

Coronary pseudoaneurysms are a known complication of the Bentall wrap-inclusion method of composite valve grafting. We describe two cases to illustrate a straightforward technique for repair and prevention of coronary pseudoaneurysm formation.

170

Coronary pseudo-lesions induced in the left anterior descending and right coronary artery by the angioplasty guide-wire

171

Coronary reactivity to nitroglycerin: Intravascular ultrasound evidence for the importance of plaque distribution

172

Coronary Recanalization by Elective Angioplasty Prevents Ventricular Dilation After Anterior Myocardial Infarction

173

Coronary recanalization in anterior myocardial infarction: The open perforator hypothesis

174

Coronary Reimplantation After Neoaortic Reconstruction Can Yield Better Result in Arterial Switch Operation: Comparison With Open Trap Door Technique

175

Coronary Reimplantatıon After Neoaortic Reconstruction in Arterial Switch Operation

176

Coronary Reimplantation During Jatene Procedure

177

Coronary reimplantation in aortic root replacement: a method to avoid tension

178

Coronary remodeling of proximal and distal stenotic atherosclerotic plaques within the same artery by intravascular ultrasound study

179

Coronary reoperation via small laparotomy using right gastroepiploic artery without CPB

180

Coronary reoperations: recurrence of angina and clinical outcome with and without cardiopulmonary bypass

181

Coronary reperfusion: numerators searching for denominators

182

Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents

183

Coronary restenosis: a new strategy for the future?

184

Coronary restenosis: a review of mechanisms and management

185

Coronary Revascularization and Cardiac Catheterization in the United States: Trends in Racial Differences

186

Coronary revascularization and quality of life

187

Coronary Revascularization Before Noncardiac Vascular Surgery: One More Step Forward in Understanding Its Role

188

Coronary Revascularization for Patients With Diabetes: Updated Data Favor Coronary Artery Bypass Grafting

189

Coronary revascularization in older women and men in the United States: trends in ethnic differences

190

Coronary Revascularization in the Community: A Population-Based Study, 1990 to 2004 Original Research Article

191

Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction

192

Coronary revascularization is under-utilized in medicaid patients with acute myocardial infarction

193

Coronary revascularization of the circumflex

194

Coronary Revascularization Strategies in Patients With Diabetes and Multivessel Coronary Artery Disease: Has the Final Chapter Been Written?

195

Coronary Revascularization Strategy and Outcomes According to Blood Pressure (from the International Verapamil SR-Trandolapril Study [INVEST])

196

Coronary Revascularization Surgery After Myocardial Infarction: Impact of Bypass Surgery on Survival After Thrombolysis

197

Coronary revascularization with arterial conduits collateral to the lower limb

198

Coronary revascularization with or without cardiopulmonary bypass in patients with preoperative nondialysis-dependent renal insufficiency

199

Coronary revascularization without cardiopulmonary bypass in high-risk patients: a route to the future

200

Coronary revascularization without cardiopulmonary bypass in patients with pectus excavatum

201

Coronary Revascularization Without Cardiopulmonary Bypass Versus the Conventional Approach in High-Risk Patients

202

Coronary risk assessment in women

203

Coronary risk assessment in women

204

Coronary risk assessment methods and cholesterol lowering

205

Coronary risk assessment methods and cholesterol lowering

206

Coronary risk assessment methods and cholesterol lowering

207

Coronary risk assessment methods and cholesterol lowering

208

Coronary risk assessment methods and cholesterol lowering

209

Coronary risk assessment methods and cholesterol lowering

210

Coronary risk assessment methods and cholesterol lowering

211

Coronary risk factor status after percutaneous transluminal coronary angioplasty

212

Coronary risk factors and coronary atheroma burden at severely narrowing segments

213

Coronary risk factors and inflammation in patients with coronary artery disease and internal cardioverter defibrillator implants

214

Coronary Risk Factors and Myocardial Perfusion in Asymptomatic Adults: The Multi-Ethnic Study of Atherosclerosis (MESA) Original Research Article

215

Coronary risk factors in Indians

216

Coronary risk factors in patients with early-onset coronary disease and normal coronariography

217

Coronary risk factors in people from the Indian subcontinent

218

Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India

219

Coronary risk factors in women six months after coronary artery bypass grafting

220

Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: The muscatine study

221

Coronary risk reduction through intensive community-based lifestyle intervention: the Coronary Health Improvement Project (CHIP) experience

222

Coronary Risk Stratification, Discrimination, and Reclassification Improvement Based on Quantification of Subclinical Coronary Atherosclerosis: The Heinz Nixdorf Recall Study

223

Coronary rotational ablation for calcific coronary artery stenosis in a young child

224

Coronary ruptured plaque mimicking spontaneous coronary dissection in a young woman

225

Coronary Segmental Responses to Acetylcholine and Bradykinin in Patients With Atherosclerotic Risk Factors

226

Coronary sinus adrenomedullin rises in response to myocardial injury

227

Coronary Sinus and Ascending Aortic Levels of Aldosterone, Angiotensin II, and B-Type Natriuretic Peptide in Patients With Aortic Stenosis and in Patients With Coronary Heart Disease

228

Coronary sinus catheterization via a femoral vein

229

Coronary sinus dilatation is a sign of impaired right ventricular function in patients with heart failure

230

Coronary sinus diverticulum as a cause of resistant posteroseptal pathway ablation

231

Coronary sinus interventions in cardiac surgery, 2nd edition: Edited by Werner Mohl, MD, PhD, Georgetown, Texas, Landes Bioscience, 2000, 224 pp, illustrated, $99.00, ISBN: 1-58706-006-X

232

Coronary Sinus Orifice Atresia With Left Superior Vena Cava in Patients With Univentricular Heart

233

Coronary sinus ostial atresia with persistent left superior vena cava

234

Coronary sinus ostial atresia: A rare associated anomaly that should be remembered in patients undergoing univentricular palliation

235

Coronary sinus pacing mistaken as interventricular septal perforation and subsequent left ventricular pacing by a transvenously introduced pacing electrode

236

Coronary Sinus Reducer Stent for the Treatment of Chronic Refractory Angina Pectoris: A Prospective, Open-Label, Multicenter, Safety Feasibility First-in-Man Study Original Research Article

237

Coronary Sinus Stenting for the Management of Left Ventricular Lead Displacement during Resynchronization Therapy: A Report of Two Cases

238

Coronary sinus thrombosis after cannulation during cardiopulmonary bypass

239

Coronary Slow Flow Phenomenon Clinical Findings and Predictors

240

Coronary slow flow: Benign or ominous?

241

Coronary Slow-Flow Phenomenon or Syndrome Y: A Microvascular Angina Awaiting Recognition

242

Coronary spasm after injection of ondansetron: Case report and review of the literature

243

Coronary spasm and hypersensitivity to amoxicillin: Kounis or not Kounis syndrome?

244

Coronary Stenosis Detection by 16-Slice Computed Tomography in Heart Transplant Patients: Comparison With Conventional Angiography and Impact on Clinical Management Original Research Article

245

Coronary stenosis dilatation induced by L-arginine

246

247

Coronary stent assessment on multidetector computed tomography: Source and predictors of image distortion

248

Coronary Stent Design and New Clinical Trial Insights

249

Coronary Stent Fracture and In-Stent Restenosis at Coronary Computed Tomography

250

Coronary stent fracture and restenosis in the drug-eluting stent era: Do we have clues of management?

251

Coronary stent fracture in a saphenous vein graft to right coronary artery — Successful treatment by the novel use of the Jomed coronary stent graft: Case report and review of the literature

252

Coronary stent grafts covered by a polytetrafluoroethylene membrane

253

Coronary stent implantation changes 3-D vessel geometry and 3-D shear stress distribution

254

Coronary stent implantation in acute myocardial infarction,

255

Coronary stent implantation in patients older than 75 years of age: Clinical profile and initial and long-term (3 years) outcome

256

Coronary stent implantation is superior to balloon angioplasty for chronic coronary occlusions: Six-year clinical follow-up of the GISSOC trial

257

Coronary stent implantation may seal the inflammatory response in patients with acute coronary syndromes

258

Coronary stent occlusion following strenuous exertion: is the risk actual? Is it preventable?

259

Coronary stent occlusion: Thrombus horribilis

260

Coronary Stent Placement in Patients With Acute Myocardial Infarction: Comparison of Clinical and Angiographic Outcome After Randomization to Antiplatelet or Anticoagulant Therapy

261

Coronary Stent Thrombosis in the Current Drug-Eluting Stent Era: Insights From the ERACI III Trial

262

Coronary Stent Thrombosis With Vorapaxar Versus Placebo: Results From the TRA 2°P-TIMI 50 Trial

263

Coronary stenting after rotational atherectomy in diffuse lesions of the small coronary artery: comparison with balloon angioplasty prior to stenting

264

Coronary stenting after unsuccessful emergency angioplasty in acute myocardial infarction: Results in a series of consecutive patients

265

Coronary Stenting and Inflammation

266

Coronary Stenting and Inflammation: Implications for Further Surgical and Medical Treatment

267

Coronary stenting and use of abciximab

268

Coronary stenting during acute myocardial infarction. Results from the stent without coumadin French registry

269

Coronary stenting for transplant coronary artery disease

270

Coronary stenting for treatment of ostial stenoses of native coronary arteries or aortocoronary saphenous venous grafts

271

Coronary stenting in cardiac allograft vasculopathy

272

Coronary stenting in diabetic patients: Results from the ROSETTA registry

273

Coronary stenting in patients undergoing percutaneous transluminal coronary angioplasty during acute myocardial infarction

274

Coronary stenting in the setting of spontaneous coronary artery dissection

275

Coronary stenting of bifurcation lesions using “T” or “reverse Y” configuration with Wiktor stent

276

Coronary stenting of unprotected left main stem stenoses in elderly patients unsuitable for coronary surgery

277

Coronary stenting or percutaneous transluminal coronary angioplasty prior to noncardiac surgery increases adverse perioperative cardiac events: the evidence is mounting

278

Coronary stenting or percutaneous transluminal coronary angioplasty prior to noncardiac surgery increases adverse perioperative cardiac events: the evidence is mounting: Reply

279

Coronary stenting versus balloon angioplasty for acute myocardial infarction: A meta-regression analysis of randomized trials

280

Coronary stenting versus balloon angioplasty in small vessels

281

Coronary stenting versus balloon angioplasty in small vessels: A meta-analysis from 11 randomized studies Original Research Article

282

Coronary stenting with novel stainless steel balloon-expandable stent: Determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model

283

Coronary stenting with angioscopic guidance

284

Coronary stenting with AVE microstents in acute myocardial infarction

285

Coronary stents: A health system perspective, ,

286

Coronary stents: A materials perspective

287

Coronary stents: An industry perspective, ,

288

Coronary stents—open choices for closed arteries

289

Coronary subclavian steal: A recurrent case with notes on detecting the threat potential

290

Coronary Superficial and Spotty Calcium Deposits in Culprit Coronary Lesions of Acute Coronary Syndrome as Determined by Optical Coherence Tomography

291

Coronary surgery in patients with peripheral vascular disease: effect of avoiding cardiopulmonary bypass

292

Coronary Surgery in Patients With Preexisting Chronic Atrial Fibrillation: Early and Midterm Clinical Outcome

293

Coronary surgery with intermittent aortic cross-clamping: a word of caution on the incidence of cerebrovascular accidents: letter 2

294

Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response

295

Coronary syndromes following aspirin withdrawal: A special risk for late stent thrombosis Original Research Article

296

Coronary thrombosis

297

Coronary thrombosis associated with inherited protein S deficiency: A case report

298

Coronary Thrombosis From Large, Nonprotruding, Superficial Calcified Coronary Plaques

299

Coronary Thrombosis without Dissection following Blunt Trauma

300

Coronary to pulmonary artery collaterals in patients with pulmonary atresia and ventricular septal defect

301

Coronary to pulmonary artery fistula detected by transthoracic echocardiography

302

Coronary tracheal collaterals after heart–lung transplant

303

Coronary vascular dysfunction in premenopausal women with diabetes mellitus

304

Coronary Vascular Morphology in Pressure-overload Left Ventricular Hypertrophy

305

Coronary vascular reactivity is abnormal in patients with Chagasʹ heart disease

306

Coronary Vascular Remodeling in Association With Endothelial Dysfunction

307

Coronary vascular reserve is similarly reduced in hypertensive patients without any other coronary risk factors and in normotensive smokers and hypercholesterolemic patients with angiographically normal coronary arteries

308

Coronary vascular responses to short-term cocaine administration in conscious baboons compared with dogs

309

Coronary Vascular Responsiveness to Adenosine Is Impaired Additively by Blockade of Nitric Oxide Synthesis and Sulfonylure

310

Coronary vasoconstriction after coronary angioplasty is attenuated by endothelin a receptor antagonism

311

Coronary vasoconstriction induced by mental stress (simulated public speaking)

312

Coronary Vasoconstrictive Effects of Neuropeptide Y and Their Modulation by the ATP-Sensitive Potassium Channel in Anesthetized Dogs

313

Coronary vasodilation by noninvasive transcutaneous ultrasound: An in vivo canine study

314

Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction

315

Coronary vasodilator reserve: a clue to the explanation of 201Tl redistribution patterns early after successful primary stenting for acute myocardial infarction

316

Coronary vasodilator responses to bradykinin in euglycemic and diabetic rats

317

Coronary vasodilatory capacity and flow reserve are attenuated in normal myocardium supplied by bypass grafts

318

Coronary vasodilatory capacity and flow reserve in normal myocardium supplied by bypass grafts late after surgery

319

Coronary vasomotility and myocardial blood flow early after heart transplantation

320

Coronary Vasomotion After Percutaneous Transluminal Coronary Angioplasty Depends on the Severity of the Culprit Lesion

321

Coronary vasomotion and exercise‑induced adaptations in coronary artery disease patients: A systematic review and meta‑analysis

322

Coronary vasomotion during dynamic exercise: Influence of intravenous and intracoronary nicardipine

323

Coronary vasomotor function in a normotensive, nondiabetic referral population with normal coronary arteriograms

324

Coronary vasomotor reactivity among normotensive african and white american subjects with chest pain

325

Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: Contrasting myocardial blood flow responses to short- and long-term vitamin C administration

326

Coronary Vasospasm and Coronary Atherosclerosis: Do We Have to Choose?

327

Coronary vasospasm and raspberry ketones weight-loss supplement: Is there a connection?

328

Coronary vasospasm as a cause of effort-related myocardial ischemia during low-dose chronic continuous infusion of 5-fluorouracil

329

Coronary vasospasm as a possible cause of elevated cardiac troponin I in patients with acute coronary syndrome and insignificant coronary artery disease

330

Coronary vasospasm due to hypercholinergic crisis: An example of normal coronary arteriogram and myocardial infarction

331

Coronary vasospasm during an adenosine stress test

332

Coronary vasospasm in a patient suffering from sarin poisoning

333

Coronary Vasospasm Induced During Isoproterenol Head-Up Tilt Test

334

Coronary vasospasm secondary to hypercholinergic crisis: An iatrogenic cause of acute myocardial infarction in myasthenia gravis

335

Coronary vasospasm-induced acute coronary syndrome complicated by life-threatening cardiac arrhythmias in patients without hemodynamically significant coronary artery disease

336

Coronary vein balloon angioplasty forleft ventricular pacemaker lead implantation

337

Coronary venous angioplasty to a ring- like stricture preventing left ventricular lead insertion

338

Coronary venous imaging with electron beam computed tomographic angiography: Three-dimensional mapping and relationship with coronary arteries

339

Coronary ventricular fistula as a complication of PTCA: A case report and literature review

340

Coronary vessel trees from 3D imagery: A topological approach

341

Coronary wallstents show significant late, postprocedural expansion despite implantation with adjunct high-pressure balloon inflations

342

Coronary-artery bypass surgery and the brain: persisting concerns

343

Coronary-Artery Stent

344

Coronary-Cameral Fistula Connecting the Left Anterior Descending Artery and the First Obtuse Marginal Artery to the Left Ventricle: A Rare Finding

345

Coronary-cameral fistula in an asymptomatic adult patient

346

Coronary-coronary bypass using the radial artery

347

Coronary-coronary radial artery graft for single, distal LAD lesion

348

Coronary-pulmonary artery fistula: Heart-on-a-heart appearance

349

Coronary-pulmonary fistula serving as a collateral source to the occluded coronary artery in a patient with myocardial infarction

350

Coronary-pulmonary steal syndrome

351

Coronary-Subclavian Steal Syndrome Following CABG: a Case Report and Literature Review

352

Coronary-subclavian steal syndrome in a hemodialysis patient with ipsilateral subclavian artery occlusion and contralateral vertebral artery stenosis “Case Report”

353

Coronary–Subclavian Steal Syndrome: An usual cause of refractory unstable angina

354

Coronary-to-coronary bypass using a free internal mammary artery: An alternative

355

Coronas and iridescence in mountain wave clouds

356

Coronas of balleans

357

CORONAS-F observations of active phenomena on the sun Original Research Article

358

CORONAS-F satellite: Tasks for study of particle acceleration Original Research Article

359

Coronatine alleviates salinity stress in cotton by improving the antioxidative defense system and radical-scavenging activity

360

Coronatine, a more powerful elicitor for inducing taxane biosynthesis in Taxus media cell cultures than methyl jasmonate

361

Coronavirus (COVID-19) and Possibilities for Criminal Law Reaction in Europe: A Review

362

Coronavirus (COVID-19) Infection in Newborns

363

Coronavirus (SARS-CoV-2) Deactivation via Spike Glycoprotein Shielding by Old Drugs: Molecular Docking Approach

364

Coronavirus and Divine Justice and its Relation to the Issue of Natural and Moral Evil

365

Coronavirus and Emergence of an Extraordinary Political Economy: editorial note

366

Coronavirus Anxiety: The Predictive Role of Perfectionism and Self-compassion

367

Coronavirus as a possible cause of severe acute respiratory syndrome

368

Coronavirus confirmed as cause of SARS

369

Coronavirus COVID-19 and its Effect on Erection and Patients’ Sexual Disorders: A Narrative Review

370

Coronavirus Disease (COVID-19) and Dental Treatment

371

Coronavirus Disease (COVID-19): 10 Questions and Discussion Points for Diabetes and COVID-19

372

Coronavirus Disease 19 with Spontaneous Pneumomediastinum: A Report of Three Cases

373

Coronavirus disease 2019 (COVID-19) and cardiovascular events

374

Coronavirus disease 2019 (COVID-19) and pediatric gastroenterology

375

Coronavirus Disease 2019 (COVID-19) in adolescents: An update on current clinical and diagnostic characteristics

376

Coronavirus Disease 2019 (Covid-19) in Middle East: Data, Facts and Doubts

377

Coronavirus disease 2019 (COVID-19) manifestations during pregnancy in all three trimesters: A case series

378

Coronavirus Disease 2019 (COVID-19) Outbreak in Pediatrics and the Role of Pediatricians: A Systematic Review

379

Coronavirus Disease 2019 (COVID-19): A Systematic Review of Pregnancy and the Possibility of Vertical Transmission

380

Coronavirus Disease 2019 (COVID-19): review study

381

Coronavirus Disease 2019- Challenges Today and Tomorrow in Orthodontic Practice: A Review

382

Coronavirus Disease 2019 in Children with Acute Respiratory Infection: A Study From Southeastern Iran

383

Coronavirus Disease 2019 in Patients with Thalassemia; Emerging Challenges

384

Coronavirus Disease 2019 Occupational Considerations for Surgeons: A Review Article

385

Coronavirus Disease 2019 Vaccine Hesitancy in the Kurdistan Region: A Cross-Sectional National Survey

386

Coronavirus disease 2019: Global Contamination and Global Cleanup

387

Coronavirus Disease 2019: Latest Data on Neuroinvasive Potential

388

Coronavirus Disease in Cardiovascular Patients: Clinical Characteristics and Final Prognosis

389

Coronavirus Disease-19 (COVID-19) Presenting with Severe Acute Pancreatitis: A Case Report from Iran

390

Coronavirus Disease-2019 Infection in Neonates of an Infected Pregnant Mother with Triplets

391

Coronavirus in severe acute respiratory syndrome (SARS)

392

Coronavirus Incidence Rate Estimation from Social Media Data in Iran

393

Coronavirus infections in children: from SARS and MERS to COVID-19, a narrative review of epidemiological and clinical features

394

Coronavirus N Protein N-Terminal Domain (NTD) Specifically Binds the Transcriptional Regulatory Sequence (TRS) and Melts TRS-cTRS RNA Duplexes

395

Coronavirus Pandemic and Worries during Pregnancy; a Letter to Editor

396

Coronavirus phylogeny based on triplets of nucleic acids bases

397

Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction due to Attenuated Pathogenicity and Booster Vaccine Doses

398

Coronavirus, Its Neurologic Manifestations, and Complications

399

Coronavirus: Bibliometric analysis of scientific publications from 1968 to 2020

400

Coronavirus: Discover the Structure of Global Knowledge, Hidden Patterns & Emerging Events

401

Coronavirus: Nursing Students’ Knowledge and Risk Perception of Clinical Practice during the Pandemic

402

Coronavirus: Where Has All the Health Economics Gone?

403

Coronaviruses and gastrointestinal symptoms: an old liaison for the new SARS-CoV-2

404

Coronaviruses Pathogens in Human in Third Millennium (SARS-CoV, MERS, COVID-19): A Review Article

405

Coronavirus-induced Anxiety among Pregnant Women

406

Coronavirus-nephropathy; renal involvement in COVID-19

407

Coronavirus-Related Opportunities for Promoting Occupational Health and Safety

408

Coroner autopsies originating from complaints to the police in a Nigerian Urban centre

409

Coroner Wakley: two remarkable eyewitness accounts

410

Coroners and public health

411

Coronilla juncea is both a nutritive fodder shrub and useful in the rehabilitation of abandoned Mediterranean marginal farmland

412

Coronin 1B Antagonizes Cortactin and Remodels Arp2/3-Containing Actin Branches in Lamellipodia

413

Coronin 1B Coordinates Arp2/3 Complex and Cofilin Activities at the Leading Edge

414

Coronin-1A Stabilizes F-Actin by Bridging Adjacent Actin Protomers and Stapling Opposite Strands of the Actin Filament

415

Coronoid systems with perfect matchings Original Research Article

416

Corono-radicular biological restoration of maxillary central incisors by direct method

417

Corosolic acid induces apoptosis through mitochondrial pathway and caspases activation in human cervix adenocarcinoma HeLa cells

418

Corosolic acid induces apoptotic cell death in human lung adenocarcinoma A549 cells in vitro

419

COROT: A minisat for pionnier science, asteroseismology and planets finding Original Research Article

420

CoRoT: Harvest of the exoplanet program

421

Co-rotation constructions of residuated semigroups

422

Corotation resonances and planetary formation

423

Co-rotational beam elements with warping effects in instability problems Original Research Article

424

Co-rotational dynamic analysis of flexible beams Original Research Article

425

Co-rotational finite element formulation for thin-walled beams with generic open section Original Research Article

426

Co-rotational flat facet triangular elements for shell instability analyses Original Research Article

427

Co-rotational formulation for geometric nonlinear analysis of doubly symmetric thin-walled beams Original Research Article

428

Corotational formulation for nonlinear dynamics of beams with arbitrary thin-walled open cross-sections

429

Corotational mixed finite element formulation for thin-walled beams with generic cross-section

430

Corotational non-linear analysis of thin plates and shells using a new shell element

431

Corotational nonlinear dynamic analysis of laminated composite shells

432

CORPORA AMYLACEA IN HUMAN CADAVERIC BRAIN AGE RELATED DIFFERENCES

433

CORPORA IN LANGUAGE RESEARCH IN MALAYSIA

434

Corpora Lutea Diameter, Plasma Progesterone Concentration and Follicular Development in PGF2α and CIDR Estrus Synchronized Goats

435

CORPORA USE IN THE TEACHING OF ENGLISH WRITING

436

Corporal punishment and child adjustment

437

Corporal Punishment and its Effects in Pakistan

438

Corporal punishment and physical maltreatment against children: A community study on Chinese parents in Hong Kong

439

Corporal punishment and primary prevention of physical abuse

440

Corporate "central nervous system" software

441

Corporate and Institutional Transparency for Economic Growth in Europe, Oxelheim Lars (Ed.). Elsevier, Amsterdam (2006) 444p, € 76.99, ISBN 0-08-044665-5.

442

Corporate and social performance links in the gaming industry

443

Corporate asset purchases and sales: Theory and evidence

444

Corporate bankruptcies and official bail-outs: A cost–benefit analysis

445

Corporate behavior and competitiveness: impact of environmental regulation on Chinese firms

446

CORPORATE BLOGS AS ACORPORATECOMMUNICATION STRATEGY

447

Corporate board attributes and bankruptcy

448

Corporate boards and regulation: The effect of the Sarbanes–Oxley Act and the exchange listing requirements on firm value

449

Corporate body name changes: Helping the user search efficiently and effectively

450

Corporate bond default risk: A 150-year perspective

451

Corporate bond liquidity and matrix pricing

452

Corporate bond liquidity before and after the onset of the subprime crisis

453

Corporate bond ratings changes and economic instability: Evidence from the Korean financial crisis

454

Corporate Call Policy for Nonconvertible Bonds

455

Corporate capital structure and the characteristics of suppliers and customers

456

Corporate capital structure in turbulent times: a case study of the US airline industry

457

Corporate capture and Coca-Cola

458

Corporate cash flow and stock price exposures to foreign exchange rate risk

459

Corporate cash holdings and CEO compensation incentives

460

Corporate cash holdings: An empirical investigation of UK companies

461

Corporate Champions: doing good more effectively

462

Corporate characteristics, governance attributes and the extent of voluntary disclosure in Bangladesh

463

Corporate citizenship and public relations: The importance and interactivity of social responsibility issues on corporate websites

464

Corporate citizenship and the employee/citizen solider

465

Corporate comets or typical trajectories?: Corporate dynamics in the 1990s

466

Corporate communications managers in large firms: new challenges

467

Corporate Community Involvement. The Definitive Guide to Maximizing Your Business’ Societal Engagement

468

Corporate contracting for health care

469

Corporate control and enterprise structure in the Canadian economy: 1972–1987

470

Corporate control and industry structure in global communications: an introduction

471

Corporate control and real investment in incomplete markets

472

Corporate control and the market for managerial labour: On the decision to go public

473

Corporate control, bank risk taking, and the health of the banking industry

474

Corporate control, expected underpricing, and the choice of issuance mechanism in unseasoned equity markets

475

Corporate cost of occupational accidents: an activity-based analysis

476

Corporate Credibility’s Role in Consumers’ Attitudes and Purchase Intentions When a High versus a Low Credibility Endorser Is Used in the Ad

477

Corporate credit risk modeling and the macroeconomy

478

CORPORATE CRIME ANNOUNCEMENT EFFECTS ON STOCK PERFORMANCE: AN EMPIRICAL STUDY IN MALAYSIA

479

corporate crime in indonesian criminal law system

480

Corporate Cultural Dimensions, Social Responsibility and Financial Performance

481

Corporate Culture and Commitment: Impact on Performance of International New Product Development Programs

482

Corporate culture and the bottom line

483

Corporate culture, absorptive capacity and IT success

484

Corporate culture, related chief executive officer traits, and the development of executive information systems

485

Corporate debt and output pricing in developing countries: Industry-level evidence from Turkey

486

Corporate Default Prediction among Tehran Stock Exchange’s Selected Industries

487

Corporate derivatives use and firm value: Evidence from Turkey

488

Corporate disclosure quality, earnings smoothing, and earningsʹ timeliness

489

Corporate disclosures made by Chinese listed companies

490

Corporate distress and lobbying: Evidence from the Stimulus Act

491

Corporate diversification and asymmetric information: evidence from stock market trading characteristics

492

Corporate diversification and efficiency of manufacturing firms listed in Bursa Malaysia

493

Corporate diversification and performance: evidence on production efficiency

494

Corporate diversification and shareholder value: a survey of recent literature

495

Corporate diversification strategies and capital structure

496

Corporate diversification, information asymmetry and firm performance: Evidence from Tehran Stock Exchange

497

Corporate Diversification, Value Maximization, and Organizational Capabilities

498

Corporate diversification: identifying new businesses systematically in the diversified firm

499

Corporate diversification’s effects on Efficiency and productivity: case study of Manufacturing firms listed in Bursa Malaysia

500

Corporate dynamic transparency: the new ICT-driven ethics?

501

Corporate earnings and the equity premium

502

Corporate elites as informants in qualitative international business research

503

Corporate enterprise: a new reality for hospitality organisations?

504

Corporate entrepreneurs and privatized firms in russia, ukraine, and belarus

505

Corporate entrepreneurship and financial performance: The case of management leveraged buyouts

506

Corporate entrepreneurship antecedents and performance in agricultural advisory services corporations in west of Iran

507

Corporate entrepreneurship in network organizations:: How subsidiary initiative drives internal market efficiency

508

Corporate Entrepreneurship in Training Institutions

509

Corporate entrepreneurship:: antidote or oxymoron?

510

Corporate environme ntal behavior research: informing environme ntal policy

511

Corporate environmental and resource management: In search of a new managerial paradigm

512

Corporate environmental disclosure, financial markets and the media: An international perspective

513

Corporate environmental disclosures: are they useful in determining environmental performance?

514

Corporate environmental disclosures: Competitive disclosure hypothesis using 1991 annual report data

515

Corporate Environmental Innovation (CEI): a government initiative to support corporate sustainability leadership

516

Corporate Environmental Management 2: Culture and Organisations : , Earthscan Publications Ltd (1997) 192 £15.95. Building to Last: The Challenge for Business Leaders, , Earthscan Publications Ltd (1997) 204 £15.95

517

Corporate environmental management and regulation of mining operations in the Cyclades, Greece

518

Corporate environmental market responsiveness: A model of individual and organizational drivers

519

Corporate environmental responsibility in the supply chain

520

Corporate environmental responsiveness in India: lessons from a developing country

521

Corporate environmental strategy: The avalanche of change since Bhopal : B.W. Piasecki (author) John Wiley & Sons, 1995, 180 pp, ISBN 0-471-10627-5, US$24.95

522

Corporate environmentalism: the construct and its measurement

523

CORPORATE EQUAL OPPORTUNITIES (NON-) DISCLOSURE

524

Corporate ergonomics programme at automobiles Peugeot-Sochaux

525

Corporate ergonomics programme at BCM Airdrie

526

Corporate ergonomics programme at Ford Motor Company

527

Corporate ergonomics programme at Scottish & Newcastle

528

Corporate ergonomics programme at Volvo Car Corporation

529

Corporate Excellence in the Year 2000 : L K T , Century (1996), 350 pp., £18.99

530

Corporate Farm Performance in Russia, 1991–1995: An Efficiency Analysis

531

Corporate finance and state enterprise reform in China

532

Corporate finance—Theory and practice

533

Corporate Financial Accounting and Reporting: by Tim Sutton, Financial Times/Prentice Hall, Harlow, Essex, England, 2000, xiii+754 pp

534

Corporate financial decision-makers’ perceptions of workplace safety

535

Corporate financial disclosure in emerging markets: Does economic development matter?

536

CORPORATE FINANCIAL MANAGEMENT: TIME TO CHANGE THE “COST OF CAPITAL” PARADIGM?

537

Corporate Financial Reporting. Theory and Practice: Andrew Higson (Ed.); Sage, 2003, 228 pages, ISBN 0-7619-7141-6 (£24.99)

538

Corporate Financial Reporting: A Global Perspective: by Hervé Stolowy and Michel J. Lebas, Thomson, London, UK, 2002, xxvi+636 pp. ISBN: 1-861-52753-5, £31.99

539

Corporate Financial Reporting: By Bhabatosh Banerjee and Arun Kumar Basu (Eds.), University of Calcutta, Calcutta, 2001, vi+275 pages

540

Corporate Financial Strategies for Global Competitiveness

541

Corporate Financing and Goverance in Japan: The Road to the Future: by Takeo Hoshi and Anil Kashyap, MIT Press, 2002.

542

Corporate financing decisions when investors take the path of least resistance

543

Corporate financing decisions, managerial market timing, and real investment

544

Corporate firms in the 21st century: A note.

545

Corporate focus and stock returns,

546

Corporate focus and value creation evidence from spinoffs

547

Corporate focus versus diversification: the role of growth opportunities and cashflow

548

Corporate fraud, systematic risk, and shareholder enrichment

549

Corporate futures: social responsibility in the tourism industry: Angela Kalisch; Tourism Concern, London, 2002, 47pp, price £15 (£10 for members), ISBN 0-9528567-7-8

550

Corporate goodness and shareholder wealth

551

CORPORATE GOVERNANCE AND ACCOUNTING MODELS OF THE REPORTING ENTITY,

552

Corporate governance and accounting systems: a critical perspective

553

Corporate Governance and Audit Fees: Evidence from a Developing Country

554

Corporate Governance and Audit Opinion Shopping: Evidence from Iran

555

Corporate governance and audit report lag in Malaysia

556

Corporate governance and bank performance: A joint analysis of the static, selection, and dynamic effects of domestic, foreign, and state ownership

557

Corporate governance and board effectiveness

558

Corporate Governance and Corporate Social Responsibility: The Case of Small, Medium, and Large Firms

559

Corporate Governance and Credit Risk in the Iranian Banking Industry

560

Corporate governance and dividend pay-out policy in Germany

561

Corporate governance and dividend policy in emerging markets

562

Corporate governance and dividend policy: A comparison of Chinese firms listed in Hong Kong and in the Mainland

563

Corporate governance and earnings management in the Chinese listed companies: A tunneling perspective

564

Corporate Governance and Employee Ownership in an Economic Crisis: Enterprise Strategies in the Former USSR

565

Corporate governance and executive compensation

566

Corporate governance and firm cash holdings in the US

567

Corporate governance and firm performance: Evidence from Japanese manufacturing industries after the lost decade

568

Corporate governance and firm profitability: evidence from Korea before the economic crisis

569

Corporate governance and firm valuation

570

Corporate governance and firm value: evidence from the Korean financial crisis

571

Corporate governance and firm value\In Japan: Evidence from 1985 to 199

572

Corporate governance and globalization. Long range planning issues: Stephen S. Cohen & Gavin Boyd (Eds); Edward Elgar Publishing, Cheltenham, UK, 2000, pp. 373

573

Corporate governance and information asymmetry

574

Corporate governance and innovation: The UK compared with the US and ‘insider’ economies

575

CORPORATE GOVERNANCE AND INSTITUTIONAL INVESTORS: EVIDENCE FROM MALAYSIA

576

Corporate governance and intellectual capital

577

Corporate Governance and Investment Decisions in Deposit Money Banks in Nigeria

578

Corporate governance and investment in Central and Eastern Europe

579

Corporate governance and investment in East Asian firms—empirical analysis of family-controlled firms

580

Corporate Governance and Iranian Banking Economic Value Added

581

Corporate Governance and Liquidity Creation: Evidence from Iranian Banks

582

Corporate Governance and Liquidity Management: Evidence from Nigerian Deposit Money Banks

583

Corporate governance and lobbying strategies

584

Corporate governance and manager turnover: An unusual social experiment

585

Corporate governance and market valuation in China

586

Corporate governance and market valuation of capital and R&D investments

587

Corporate governance and mass privatisation: A theoretical investigation of transformations in legal and economic relationships

588

Corporate governance and merger performance: Learning from the Australian experience

589

Corporate governance and ownership structure of target companies and the outcome of takeovers

590

Corporate governance and pay-for-performance: The impact of earnings management

591

Corporate governance and performance of small high-tech firms in Sweden

592

Corporate governance and profit manipulation: a French field study

593

CORPORATE GOVERNANCE an‎d PUBLIC RELATIONS: A QUALITATIVE RESEARCH WITH PUBLIC RELATIONS EXPERTS

594

Corporate Governance and R D Reporting in Malaysian MESDAQ Market

595

Corporate governance and recent consolidation in the banking industry

596

CORPORATE GOVERNANCE AND ROLE OF CEO IN ENGINEERING COMPANIES

597

Corporate governance and shareholder initiatives: Empirical evidence

598

Corporate governance and shareholder patience

599

Corporate governance and state-owned shares in China listed companies

600

Corporate governance and the quality of financial analysts’ information

601

Corporate governance and the spinoff decision

602

Corporate governance and the value of cash holdings

603

Corporate governance and voluntary disclosure

604

Corporate Governance and Voluntary Disclosure Practices: Evidence from a Two Tier Board Systems in Indonesia

605

Corporate governance assessment in company board structure

606

Corporate governance attributes, firm characteristics and the level of corporate disclosure: Evidence from the Indian listed firms

607

Corporate Governance Characteristics and Company Performance

608

Corporate Governance Characteristics and Discretionary Accruals Among Non-Financial Firms Listed in Nairobi Securities Exchange

609

Corporate governance digest

610

Corporate governance effectiveness during institutional transitio

611

Corporate governance in China: An overview

612

Corporate governance in china: Explosive growth and new patterns of ownership

613

Corporate Governance in Insurance Sector and The Impact of Corporate Governance Committee

614

Corporate Governance in Russia:: towards a European, US, or Russian Model?

615

Corporate governance in South Korea: the chaebol experience

616

Corporate governance in the Asian countries

617

Corporate governance in the Asian financial crisis

618

CORPORATE GOVERNANCE IN THE CONTEXT OF CORPORATE SUSTAINABILITY: THE BIRTH, THE DEVELOPMENT an‎d THE EVALUATION OF THE CONCEPT

619

Corporate governance in the deregulated telecommunications industry: lessons from the airline industry

620

Corporate Governance in the Former Soviet Union

621

Corporate Governance in the Former Soviet Union: An Overview

622

Corporate Governance In Turkey: An Overview

623

Corporate governance indices and firmsʹ market values: Time series evidence from Russia

624

Corporate governance issues and director compensation structure in Spanish companies

625

Corporate Governance Mechanisms and Financial Performance: Evidence from the Listed Bank in Bangladesh

626

Corporate governance of Japanese banks

627

Corporate governance over the business cycle

628

Corporate Governance Perspectives for Zimbabwean SMEs

629

Corporate governance post-Enron: Effective reforms, or closing the stable door?

630

Corporate Governance Practices and Environmental Reporting of Companies in Malaysia: Finding Possibilities of Double Thumbs Up

631

Corporate Governance Practices in Bangladesh: A Comparative Analysis between Conventional Banks and Islamic Banks

632

Corporate governance practices, CEO characteristics and firm performance

633

Corporate governance proposals and shareholder activism: the role of institutional investors

634

Corporate governance provisions and firm ownership: Firm-level evidence from Eastern Europe

635

Corporate Governance Quality :A Literature Review

636

Corporate Governance Structure, Legal Environment, and Valuation

637

Corporate governance when founders are directors

638

Corporate Governance with the Institutional Theory Approach on Regional Development Banks in Indonesia

639

Corporate Governance, Accountability, and Pressures to Perform: An International Study: by Istemi S. Demirag, JAI Press, Stamford, CT, 1998, xv+395 pp.

640

Corporate governance, bank specific characteristics, banking industry characteristics, and Intellectual Capital (IC) performance of banks in Arab Gulf Cooperation Council (GCC) countries

641

Corporate governance, chief executive officer compensation, and firm performance

642

Corporate governance, competition policy and industrial policy

643

Corporate governance, corporate social responsibility and corporate risk: Evidence on Indonesia

644

Corporate governance, dividend payout policy, and the interrelation between dividends, R&D, and capital investment

645

Corporate Governance, Executive Directors and Level of Voluntary Disclosure: The Case of Public Listed Companies in Thailand

646

Corporate governance, investor protection, and performance in emerging markets

647

Corporate governance, ownership dispersion and efficiency: Empirical evidence from Austrian cooperative banking

648

Corporate governance, Sarbanes-Oxley, and small-cap firm performance

649

Corporate governance, shareholder rights and firm diversification: An empirical analysis

650

Corporate governance, strategic philanthropy, and public policy

651

Corporate governance, top executive compensation and firm performance\In Japan

652

Corporate governance, tourism growth and firm performance: Evidence from publicly listed tourism firms in five Middle Eastern countries

653

Corporate governance: Accountability, enterprise and international comparisons, 2005

654

Corporate Governance: Board Structure, Information Technology and CSR Reporting

655

CORPORATE GOVERNANCE: CAN CREDITORS FIT IN WITH COMPANIES’ BOARD OF DIRECTORS?

656

Corporate governance: Kenneth A. Kim, John R. Nofsinger; Pearson Education Inc., 94 pages, ISBN 0131423878, £19.99

657

CORPORATE GOVERNANCE: NOMINEE DIRECTOR THE GATEKEEPER

658

CORPORATE GOVERNANCE: OVERVIEW AND RESEARCH AGENDA

659

Corporate Governance: SMEs Experience in Metro Cebu, Philippines

660

Corporate Governance: Theory and Some Insights into the Malaysian Practices

661

Corporate governance\In New Zealand: The effect of the 1993 Companies Act on the relation between board composition and firm performance

662

Corporate government digest

663

Corporate groups, dual-class shares and the value of voting rights

664

Corporate Harm Minimisation: Promises and Perils; Comment on “Understanding Marketing Responses to a Tax on Sugary Drinks: A Qualitative Interview Study in the United Kingdom, 2019”

665

Corporate heritage identity management and the multi-modal implementation of a corporate heritage identity

666

Corporate identity: The role of mission statements

667

Corporate image and corporate reputation in customers’ retention decisions in services

668

Corporate image of zakat institutions in Malaysia

669

Corporate imagesʹ impact on consumersʹ product choices: The case of multinational foreign subsidiaries

670

Corporate Inertia and Information Asymmetry: Evidence from Iran

671

Corporate Information Protection Program: Concept of Operations

672

Corporate initiatives in ergonomics—an introduction

673

Corporate Insurance and Managerial Incentives

674

Corporate integration and market liberalisation in the EU

675

Corporate Integrity and Information Asymmetry: Evidence from Iran.

676

Corporate intelligence dissemination as a consequence of intranet effectiveness: an empirical study

677

Corporate international activities and cash holdings

678

Corporate Internet Reporting in Emerging Economic Countries: The Malaysian Perspective

679

Corporate investment and financing under asymmetric information

680

Corporate investment myopia: a horserace of the theories

681

Corporate investment, financing, and dividend policies in the high-tech industry

682

Corporate Killing For Malaysia: A Preliminary Consideration

683

Corporate knowledge transfer via interlocking directorates: a network analysis approach

684

Corporate Leadership: Reflections of a CEO and CEO Advisor

685

Corporate learning: A knowledge management perspective

686

Corporate leverage and currency crises

687

Corporate life cycle and share repurchases: Evidence from the Taiwan Stock Market

688

Corporate lobbying in the UK: an analysis of attitudes towards the ASBʹs 1995 deferred taxation proposals

689

CORPORATE MAKAHIKI: THE GOVERNING TELOS OF PEACE

690

Corporate management of the Northwestern Hawaiian Islands lobster fishery

691

Corporate mandatory disclosure practices in Bangladesh

692

Corporate Membership in CIRP

693

Corporate Membership in CIRP

694

Corporate Membership in CIRP

695

Corporate Membership in CIRP

696

Corporate memories as a tool for knowledge management

697

Corporate mergers and acquisitions: One more wave to consider

698

Corporate mergers and the problems of IS integration

699

Corporate mindset of innovating firms: Influences on new product performance

700

Corporate misreporting and bank loan contracting

701

Corporate motivation and performance in R&D alliances

702

Corporate ontologies and concurrent engineering

703

Corporate optimal production planning with varying environmental costs: A grey compromise programming approach

704

Corporate Ownership and Governance in Russi

705

Corporate ownership and the value of a vote in an emerging market

706

Corporate ownership structure and bank loan syndicate structure

707

Corporate ownership structure and the choice between bank debt and public debt

708

Corporate partial acquisitions, total firm valuation and the effect of financing method

709

Corporate payout policy and managerial stock incentives

710

Corporate Performance and Board Structure in Belgian Companies

711

Corporate performance and CEO compensation in China

712

Corporate performance implications of extended stakeholder management: New insights on mediation and moderation effects

713

Corporate Performance, CEO Power and CEO Turnover: Evidence from Malaysian Public Listed Companies

714

Corporate philanthropic practices

715

Corporate philanthropy, attitude towards corporations, and purchase intentions: A South Korea study

716

Corporate policies restricting trading by insiders

717

Corporate Political Activity: A Literature Review and Research Agenda

718

Corporate Political Activity: Taxonomies and Model of Corporate Influence on Public Policy

719

Corporate portal: a tool for knowledge management synchronization

720

Corporate portals: a literature review of a new concept in Information Management

721

Corporate Portfolio Analysis Tools Revisited: Assessing Causes that May Explain Their Scholarly Disdain

722

Corporate Power Strategies: Getting the Upper Hand with Interest Groups, Media and Government: Otto Lerbinger; Newton, MA, Barrington Press, 2001, 336 pp., $35

723

Corporate precautionary cash holdings

724

Corporate profit tax, capital mobility, and formula apportionment

725

Corporate Qualification of the Mentor in the Dual Education System

726

Corporate Real Estate in Malaysia Higher Learning Environment

727

Corporate Rehabilitation: Informal Corporate Rescue Mechanisms for Troubled Companies in the United Kingdom and Malaysia

728

Corporate Relations in the Hellenistic Polis

729

Corporate Religion: Jesper Kunde, Financial Times, Prentice Hall (2000), 278 pp. plus index, £24.99

730

Corporate report obfuscation: artefact or phenomenon?

731

CORPORATE REPORTING ON HUMAN RIGHTS: CONSTRUCTION COMPANIES IN MALAYSIA

732

Corporate reporting on the Internet by German companies

733

Corporate Reputation and Competitiveness: by Gary Davies, with Rosa Chun, Rui Vinhas da Silva and Stuart Roper, Routledge (2002) 272 pp., £24.99

734

Corporate reputation and the stock market

735

Corporate Reputation in Businesses, Managing and Measuring Corporate Reputation: A Research

736

CORPORATE REPUTATION OF NON-PROFIT ORGANISATIONS: KIZILAY CASE

737

Corporate Resilience and Performance in Food Industry SMEs During COVID-19

738

Corporate responses to political costs: an examination of the relation between environmental disclosure and earnings management

739

Corporate responsibility and the triple bottom line

740

Corporate responsibility and the war on terrorism

741

Corporate Responsibility for Environmental Human Rights Violation: A Case Study of Indonesia

742

Corporate responsibility for socio-economic transformation: A focus on broad-based black economic empowerment and its implementation in South Africa

743

Corporate responsibility for sustainable development: a review and conceptual comparison of market- and stakeholder-oriented strategies

744

Corporate Responsibility for Wealth Creation and Human Rights: a Book Project

745

Corporate responsibility in the UK tourism industry

746

Corporate responsibility reporting by large pulp and paper companies

747

Corporate Responsibility via Malaysian Contract Law: A Concern for Consumer Protection

748

Corporate restructuring : , Harvard Business School Press (1994), 227 pp., £25.95

749

Corporate Restructuring and Its Wealth Effects: The Case of Lion Group

750

Corporate restructuring and performance: An agency perspective on the complete buyout cycle

751

Corporate restructuring during performance declines in Japan

752

Corporate restructuring in a collusive oligopoly

753

Corporate restructuring in Japan: an event-study analysis

754

Corporate Restructuring of British and German Non-financial Firms in the Late 1990s

755

Corporate restructuring: A symptom of poor governance or a solution to past managerial mistakes?

756

Corporate Restructuring: Firm Characteristics and Performance

757

Corporate risk management and asymmetric information

758

Corporate risk management to reduce borrowing costs

759

Corporate Risk Strategy:: Does it Vary Across Business Activities?

760

Corporate risk-taking and performance: A 20 year look at the petroleum industry

761

Corporate rumor activity, belief and accuracy

762

Corporate silence: environmental disclosure and the north american free trade agreement

763

Corporate social and environmental disclosure in developing countries: Evidence from Iran

764

Corporate social and environmental responsibility in web-based reports: Currency in the banking sector?

765

Corporate social audits—this time around

766

Corporate social disclosures by listed companies on their web sites: an international comparison

767

Corporate Social Performance and Internal Control

768

Corporate social performance, financial performance and market value behavior: An information asymmetry perspective

769

Corporate social reporting and reputation risk management

770

Corporate social reporting and stakeholder accountability: The missing link

771

CORPORATE SOCIAL REPORTING PRACTICES IN WESTERN EUROPE: LEGITIMATING CORPORATE BEHAVIOUR?,

772

Corporate Social Responsibilities (CSR) Themes from Bangladesh Perspective

773

Corporate social responsibilities and stock returns: Stochastic dominance approach

774

Corporate social responsibilities, consumer trust and corporate reputation: South Korean consumersʹ perspectives

775

Corporate Social responsibilities, their concepts and standards

776

Corporate Social Responsibility

777

Corporate social responsibility (CSR)

778

Corporate Social Responsibility (CSR) Employee Outcomes in the Aviation Industry during the COVID-19 Pandemic Era. A Conceptual Framework

779

Corporate Social Responsibility (CSR) initiatives in elevating community capacity building: The case of chilli farming in Bukit Awang, Pasir Puteh, Kelantan

780

Corporate social responsibility and CEO risk incentives from the behavioral agency model perspective Implications for idiosyncratic risk

781

Corporate Social Responsibility and community development: Perspective of the recepients

782

Corporate social responsibility and consumersʹ attributions and brand evaluations in a product–harm crisis

783

Corporate social responsibility and environme ntal research and developme nt

784

Corporate social responsibility and firm performance in the airline industry: The moderating role of oil prices

785

Corporate social responsibility and food risk management in China; a management perspective

786

Corporate Social Responsibility and Investor’s Intention to Invest: Analyzing the Role of Corporate Identity and Corporate Image

787

Corporate Social Responsibility and Labor-Managed Duopoly with Wage Rise as Strategic Commitment

788

Corporate Social Responsibility and Poor’s Child Well Being in Developing Customer’s Loyalty

789

Corporate Social Responsibility and Reaction Functions of Labor-Managed Firms with Lifetime Employment as Strategic Commitment

790

Corporate social responsibility and stakeholder value maximization: Evidence from mergers

791

Corporate Social Responsibility and Stock Price Crash Risk: Evidence from an Emerging Market

792

Corporate social responsibility and the case of Summitville mine

793

Corporate social responsibility and tourism: Hotel companies in Phuket, Thailand, after the Indian Ocean tsunami

794

Corporate social responsibility and universities: A study of top 10 world universitiesʹ websites

795

Corporate Social Responsibility and Value at Risk: Petrochemical Companies listed on Tehran Stock Exchange

796

CORPORATE SOCIAL RESPONSIBILITY COMMUNICATION OF LEADING TURKISH CORPORATIONS: AN OBSERVATION OF WEB SITES

797

Corporate social responsibility disclosure in Kenya: The Nairobi stock exchange

798

Corporate Social Responsibility Disclosure: A Tawhidic Approach

799

Corporate Social Responsibility Disclosures and Board Structure: Evidence from Malaysia

800

CORPORATE SOCIAL RESPONSIBILITY EFFECT ON CONSUMER PATRONAGE-MANAGEMENT PERSPECTIVE: CASE STUDY OF A TELECOMMUNICATION COMPANY IN NIGERIA

801

Corporate social responsibility for implementation of sustainable energy development in Baltic States

802

Corporate social responsibility in fortune magazineʹs top 50 companies: State of action and salient trends

803

Corporate Social Responsibility in Global Supply Chains: A Procedural Justice Perspective

804

Corporate Social Responsibility in Iranian Agricultural Sector Governmental Public Policy Making necessities in AgriBusiness Partnerships

805

Corporate Social Responsibility in the Coffee Sector:: The Dynamics of MNC Responses and Code Development

806

Corporate social responsibility in the mining industry: Exploring trends in social and environmental disclosure

807

Corporate social responsibility in the relationship between accounting conservatism and investment efficiency

808

Corporate Social Responsibility in the Wake of the Asian Tsunami:: A Comparative Case Study of Two Sri Lankan Companies

809

Corporate social responsibility in times of financial crisis

810

CORPORATE SOCIAL RESPONSIBILITY OF MAJOR COMPANIES IN INDIA

811

Corporate Social Responsibility of Northwestern University

812

Corporate Social Responsibility Partnership to Alleviate Poverty in Kulon Progo Regency

813

Corporate social responsibility practice in resolving conflict of interests in a sustainable supply chain

814

Corporate social responsibility strategies, dynamic capability and organizational performance: Cases of top Taiwan-selected benchmark enterprises

815

Corporate Social Responsibility- Sustainability Nexus: A Systematic Literature Review and Bibliometric Analysis

816

Corporate Social Responsibility to Employees: Considering Common Law Vis-à-vis Islamic Law Principles

817

Corporate Social Responsibility, Challenges, Prospects and Its Impact on Infrastructural Developments in West African Economies

818

Corporate social responsibility, mining and “audit culture”

819

Corporate Social Responsibility: A Stakeholder and Process Approach

820

Corporate social responsibility: Doing well by doing good

821

Corporate social responsibility: The disclosure–performance gap

822

Corporate Social Responsibility: Trends and Development In Malaysia

823

Corporate Social Responsibility:: Moving Beyond Investment Towards Measuring Outcomes

824

Corporate Social Responsiveness:: Exploring the Dynamics of “Bad Episodes”

825

Corporate spinoffs and information asymmetry between investors

826

Corporate spin-offs as a value enhancing technique when faced with legal liability

827

Corporate spin-offs, bankruptcy, investment, and the value of debt

828

Corporate sponsorship questioned

829

Corporate strategic technological partnerships in the European information and communications technology industry

830

Corporate strategies for the Asia Pacific region

831

Corporate strategies, environmental forces, and performance measures: a weighting decision support system using the k-nearest neighbor technique

832

Corporate strategy

833

Corporate strategy and parenting theory

834

Corporate strategy and the environment: a portfolio approach

835

Corporate strategy for tourism : John Tribe International Thomson Business Press London (1997) 214 pp, 45 figures, 22 tables, bibliography, index, price ??? ISBN 0 415 14204 0

836

Corporate strategy in a small open economy: reducing product diversification while increasing international diversification

837

Corporate strategy in multibusiness firms

838

Corporate Structure and Equity Offerings: Are There Benefits to Diversification?

839

Corporate Structure Events Involving Regulated Utilities: The Need for a Multidisciplinary, Multijurisdictional Approach

840

Corporate sustainability disclosure practices of selected banks: A trend analysis approach

841

CORPORATE SUSTAINABILITY IN SPORTS and ERP SYSTEM (EXAMPLE OF FENERBAHÇE SPORTS CLUB)

842

Corporate sustainability ratings: an investigation into how corporations use the Dow Jones Sustainability Index

843

Corporate sustainability reporting and the relations with evaluation and management frameworks: the Portuguese case

844

Corporate sustainability reporting index and baseline data for the cruise industry

845

Corporate sustainability: an integrative definition and framework to evaluate corporate practice and guide academic research

846

Corporate takeovers, firm performance, and board composition

847

Corporate tax avoidance and high-powered incentives

848

Corporate tax avoidance and stock price crash risk: Firm-level analysis

849

Corporate tax competition, tariffs and multinational firms

850

Corporate tax competition, tariffs and multinational firms

851

Corporate tax effects on the quality and quantity of FDI

852

Corporate tax policy, foreign firm ownership and thin capitalization

853

Corporate tax systems, multinational enterprises, and economic integration

854

Corporate taxation, debt financing and foreign-plant ownership

855

Corporate taxation, incumbency advantage and entry

856

Corporate Taxes 2001–2002/Individual Taxes 2001–2002—Worldwide Summaries: Compiled by PricewaterhouseCoopers, John Wiley & Sons, Inc., New York City, 2001, 922/573 pp. (US$190 for the 2-volume set)

857

Corporate taxes and intra-firm trade

858

Corporate taxes, growth and welfare in a Schumpeterian econom

859

corporate taxpayer compliance: slippery slope framework and planned behavior theory approaches

860

Corporate technological competence and the evolution of technological diversification: Felicia M. Fai, Cheltenham. Edward Elgar publishing. 2003. 194pp.

861

Corporate technology out-licensing: Motives and scope

862

Corporate Training for Effective Performance: edited by Martin Mulder, Wim J. Nijhof, and Robert O. Brinkerhoff. Kluwer Academic, Boston 1995

863

Corporate transparency, cream-skimming and FDI

864

Corporate Universities and Corporation- University Partnerships in Thailand: Complementing Education in Learning, Leadership and Change

865

Corporate use of derivatives and excess value of diversification

866

Corporate use of interest rate swaps: Theory and evidence

867

Corporate valuation and the resolution of bank insolvency in East Asia

868

Corporate valuation around the world: The effects of governance, growth, and openness

869

Corporate valuation, capital structure and risk management: A stochastic DCF approach

870

Corporate venture capital and the returns to acquiring portfolio companies

871

Corporate venture capital as a means of radical innovation: Relational fit, social capital, and knowledge transfer

872

Corporate versus independent new ventures: Resource, strategy, and performance differences

873

Corporate voting: Evidence from charter amendment proposals

874

Corporate Wellness Programs: Implementation Challenges in the Modern American Workplace

875

Corporation Identity: Associations of Logo and Color

876

Corporation nation: How corporations are taking over our lives and what we can do about it : by Charles Derber. New York: St. Martinʹs Press, 1998. 374 pp

877

Corporation-bashing in documentary film: A case study of news media coverage organizational response

878

Corporations and Health: The Need to Combine Forces to Improve Population Health

879

Corporations Response to the Energy Saving and Pollution Abatement Policy

880

Corporations vs. communities: Evolution of wireless services in the US and the devolution of local control

881

Corporatisation and accounting change: The role of accounting and accountants in a Malaysian public utility

882

Corporatism and structural change in the British accountancy profession, 1930–1957

883

Corporatism as an impediment to ecological sustenance: the case of Finnish waste management

884

Corporatism packaged in pluralist ideology: the case of Slovenia

885

Corporatism, labor unions and the safety net

886

CORPORATIZATION AND THE REGULATION OF ACCOUNTING SERVICES,

887

Corporeal creations

888

Corporeal Experience: A Haptic Way of Knowing

889

890

Corporectomy with and without bone graft for multilevel cervical spondylosis and ossification of the posterior longitudinal ligament

891

Corporeographies of pregnancy: bikini babes

892

Corprological and haematological parameters of albino mice (Mus musculus) concurrently infected with Heligmosomoides bakeri and Trypanosoma brucei

893

Corprological and Haematological Profile of Polo Horses Stabled in North – Central Nigeria

894

Corps enveloppants des algèbres de type Witt

895

Corps et modèles—Essai sur lʹhistoire de lʹalgèbre réelle.By Hourya Sinaceur. Paris: Librairie Philosophique J. Vrin

896

Corps pythagoriciens, fermatiens et P-réduisants Original Research Article

897

Corpse medicine: mummies, cannibals, and vampires

898

Corpses and the spread of cholera

899

Corpses and the spread of cholera

900

Corpus callosal morphology in early onset adolescent depression

901

Corpus callosotomy

902

Corpus callosotomy in a patient of hemimegalencephaly and Lennox–Gastaut syndrome

903

Corpus callosum and optic chiasm in early blind adults

904

Corpus callosum atrophy and neuropsychological outcome following carbon monoxide poisoning

905

Corpus callosum changes following shunting for hydrocephalus: case report and review of the literature

906

Corpus callosum defect with dilated lateral ventricles and an occipital cyst in an Egyptian child with Diamond-Blackfan anemia

907

Corpus Callosum Functional Activities in Children with Cerebral Palsy

908

Corpus callosum lipoma and complex partial seizures

909

Corpus callosum morphology, as measured with MRI, in dyslexic men

910

Corpus callosum shape and size in male patients with schizophrenia

911

Corpus callosum size and shape in individuals with current and past depression

912

Corpus callosum size in children with developmental language disorder

913

Corpus callosum size is linked to dichotic deafness and hemisphericity, not sex or handedness

914

Corpus Coranicum Projesi: Kur’an’ı Geç Antik Döneme Ait Bir Metin Olarak Okumak

915

Corpus Design for Malay Corpus-based Speech Synthesis System

916

Corpus di italiano parlato: Vol. 1: Introduzione, Vol. 2: Corpora, CD-Rom: Emanuela Cresti, Accademia della Crusca, Firenze, 2000, 282 (Vol. 1) and 389 (Vol. 2) pages, EUR 51,65

917

CORPUS LINGUISTICS STUDIES: INTERGENERATIONAL SOLIDARITY SCALE DEVELOPMENT

918

Corpus Linguistics Tools for Loanwords and Borrowings Studies

919

Corpus luteum function following single and double ovulation during estrous cycle in Sanjabi ewes

920

Corpus luteum size and plasma progesterone concentration in cows

921

Corpus relevance through co-word analysis: An application to plant proteints

922

CORPUS RESEARCH IN MALAYSIA: A BIBLIOGRAPHIC ANALYSIS

923

Corpus-based Application for Translation of English Grammatical Collocations in Azeri

924

Corpus-based approaches and discourse analysis in relation to reduplication and repetition

925

Corpus-based Approaches to Translation Studies

926

Corpus-based cross-language information retrieval in retrieval of highly relevant documents

927

Corpus-based exploration of linking adverbials of result: Discovering what ELT writing coursebooks lack

928

corpus-based materials and learning non-congruent idioms by iranian efl learners: enhanced and unenhanced input

929

Corpus-Based Materials and Learning Non-Congruent Idioms by Iranian EFL Learners: Enhanced and Unenhanced Input

930

Corpus-Based Statistical Screening for Content-Bearing Terms

931

Corpus-Bassed Analysis for Multi-Token Unists in Persian

932

Corpuscular oxidative stress in desert sheep naturally deficient in copper

933

CorpWiki: A self-regulating wiki to promote corporate collective intelligence through expert peer matching

934

Corrasion of a remoulded cohesive bed by saltating littorinid shells

935

Correct and incorrect use of multilinear regression

936

Correct application of Fresnel’s equations for intensity analysis of angle-resolved photoemission data

937

Correct behavior identification system in a Tagged World

938

Correct body posture in nurses: an application ofmotivational interviewing

939

Correct energy conservation in geothermal wellbore simulation

940

Correct Folding of the β-Barrel of the Human Membrane Protein VDAC Requires a Lipid Bilayer

941

Correct Identification of Animal Host Species Is Important in the Diagnosis of Zoonotic Diseases

942

Correct identification of limiting water data for water network synthesis

943

Correct initial boundary value problems for dispersive equations

944

Correct interpretation of heme protein spectra allows distinguishing between the heme and the protein dynamics

945

Correct models of fuzzy IF–THEN rules are continuous

946

Correct Optimization of Drug-Eluting Stents Should Be Regarded in the Same Light as POETry

947

Correct or combine? Mechanically integrating judgmental forecasts with statistical methods

948

Correct or incorrect application of CAPM? Correct or incorrect decisions with CAPM?

949

Correct sampling and measurement—the foundation of accurate metallurgical accounting

950

Correct testing of mark independence for marked point patterns

951

Correct testing of mark independence for marked point patterns

952

Correct transformation: From object-based graph grammars to PROMELA

953

Correct use of the Langmuir–Hinshelwood equation for proving the absence of a synergy effect in the photocatalytic degradation of phenol on a suspended mixture of titania and activated carbon Original Research Article

954

Correct Utilization of Exercise Electrocardiographic Leads in Differentiation of Men With Coronary Artery Disease from Patients With a Low Likelihood of Coronary Artery Disease Using Peak Exercise ST-Segment Depression

955

Correctable and Non-Correctable Viual Impairment in a Population-Baed ample of 12-Year-Old Autralian Children Original Reearch Article

956

Correctable viual impairment in an older population: the blue mountain eye tudy

957

Corrected and Republished: A study of the impact of smartening schools on creativity and academic achievement among sixth grade students in Meybod in 1392–1393

958

Corrected and Republished: Global Health Diplomacy Fingerprints on Human Security

959

Corrected Anion Gap and Hypernatremia as Predictors of Mortality in Pediatric Intensive Care Unit, Minia University Hospital: A Retrospective Study

960

Corrected asymptotic distribution of statistics based on the multinomial law

961

Corrected confidence intervals based on the signed root transformation for multi-parameter sequentially designed experiments

962

Corrected confidence intervals following a sequential adaptive clinical trial with binary responses

963

Corrected confidence intervals for adaptive nonlinear regression models

964

Corrected confidence intervals for parameters in adaptive linear models

965

Corrected coronary flow velocity reserve: a new concept for assessing coronary perfusion

966

Corrected diffusion theory approximations in evaluating properties of SPRT charts for monitoring a process mean Original Research Article

967

Corrected discrete least-squares meshless method for simulating free surface flows

968

Corrected empirical likelihood inference for right-censored partially linear single-index model

969

Corrected equations for membrane transport characterization by manometric techniques

970

Corrected finite difference eigenvalues of periodic Sturm–Liouville problems Original Research Article

971

Corrected first-order model of DEHP degradation

972

Corrected ISICS program versions available due to a minor calculation error involving M3 X-ray production cross sections Original Research Article

973

Corrected ISICSoo class version Original Research Article

974

Corrected maximum-likelihood estimation in a class of symmetric nonlinear regression models

975

Corrected modified profile likelihood heteroskedasticity tests

976

Corrected order in the simultaneous debenzylation–acetolysis of methyl 2,3,4,6-tetra-O-benzyl-α-d-glucopyranoside

977

Corrected portmanteau tests for VAR models with time-varying variance

978

Corrected QT dispersion improves diagnostic performance of exercise testing in diagnosing coronary artery disease

979

Corrected QT Interval and QT Dispersion in Cirrhotic Patients before and After Liver Transplantation

980

Corrected QT Interval Prolongations in Patients with non–ST-Elevation Acute Coronary Syndrome

981

Corrected QT Variability in Serial Electrocardiograms in Long QT Syndrome: The Importance of the Maximum Corrected QT for Risk Stratification Original Research Article

982

Corrected relationship between %rfc/(10)X and stopping-power ratios

983

Corrected relationship between %rfc/(10)X and stopping-power ratios

984

Corrected score tests for exponential censored data

985

Corrected score tests for exponential family nonlinear models

986

CORRECTED SOLVABILITY CONDITIONS FOR NON-LINEAR ASYMMETRIC VIBRATIONS OF A CIRCULAR PLATE

987

Corrected thrombolysis in myocardial infarction frame count and ejection fraction in patients undergoing primary percutaneous coronary intervention for myocardial infarction

988

Corrected thrombolysis in myocardial infarction frame counts in diabetic patients with angiographically normal coronary arteries

989

Corrected TIMI frame count does not predict 30-day adverse outcomes after reperfusion therapy for acute myocardial infarction, ,

990

Corrected TIMI frame counts correlate with stenosis severity and infarct zone wall motion after thrombolytic therapy

991

Corrected transient energy function-based strategy for stability probability assessment of power systems

992

Corrected version of AIC for selecting multivariate normal linear regression models in a general nonnormal case

993

Correcting “witchʹs chin” by excising the ptotic soft tissue

994

Correcting a fundamental error in greenhouse gas accounting related to bioenergy

995

Correcting aggregate energy consumption data to account for variability in local weather

996

Correcting and extending the Boomsma–Poulikakos effective thermal conductivity model for three-dimensional, fluid-saturated metal foams

997

Correcting Astigmatism with Acrysof Toric Lenses (SN60T3 to SN60T9) in Cataract Surgery

998

Correcting autoimmune anomalies in autoimmune disorders by immunological means, employing the modified vaccination technique

999

Correcting AVHRR Long Term Data Record V3 estimated LST from orbital drift effects

1000

Correcting bias due to misclassification in the estimation of logistic regression models